Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults
Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, prospective post-approval clinical Phase IV study to evaluate the
safety and efficacy of Benvitimod cream, 1% twice daily for the treatment of mild to moderate
stable psoriasis vulgaris in adults. Approximately 2000 adult participants with mild to
moderate stable psoriasis vulgaris will be enrolled and they will use the Benvitimod cream at
the skin with psoriasis for 12 weeks.